NOVAVAX INC (NVAX) Stock News
NASDAQ:NVAX - Nasdaq - US6700024010 - Common Stock - Currency: USD
NVAX Latest News, Press Relases and Analysis
Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation
FDA names Vinay Prasad to lead CBER, raising questions over biologics oversight and triggering biotech stock losses and analyst concerns.
ANI Pharmaceuticals to Report Q1 Earnings: Is a Beat in the Cards?
ANIP's first-quarter 2025 revenues are likely to have been driven by increased sales of its lead product, Cortrophin Gel, and other rare disease products.
ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
ANI (ANIP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mentions: ANIP
Zoetis Gears Up to Report Q1 Earnings: Here's What to Expect
ZTS' higher companion animal product sales are likely to have driven revenues in first-quarter 2025 in both the United States and International segments.
Novavax Tops Weekly Retail Buzz Spike Amid FDA Trial Drama, COVID-19 Vaccine Approval Hopes
Optimism was tempered by a Wall Street Journal report on Friday, which said federal regulators had asked Novavax to conduct another randomized clinical trial of its COVID-19 vaccine.
4 Pipeline Stocks to Buy With $1,000 and Hold Forever
Pipeline companies remain well positioned despite the current disruption in the energy markets. At the same time, demand for natural gas is growing. This is coming from the increased power consumption stemming from artificial intelligence (AI), as well as from export demand from Mexico and for LNG (liquified natural gas) to Asia and Europe.
Starbucks Corporation (SBUX): One of the Best Dividend Stocks to Buy for Long-Term Passive Income
We recently published a list of the 15 Best Dividend Stocks to Buy for Long-Term Passive Income. In this article, we are going to take a look at where Starbucks Corporation (NASDAQ:SBUX) stands against other best dividend stocks for long-term income. Passive income, which refers to money earned with little ongoing effort, was once largely the […]
Novavax Falls on Report That FDA Wants New Covid Vaccine Trial
Novavax Inc. shares fell after the Wall Street Journal reported that US regulators asked the company to conduct another clinical trial of its Covid vaccine.
Why Summit Therapeutics Rocketed Double-Digits Today
Shares of lung cancer biotech Summit Therapeutics (NASDAQ: SMMT) rocketed 14.7% on Wednesday as of 1:45 p.m. ET. Summit disclosed some preliminary results of its HARMONi-6 trial, conducted in partnership with Akeso. In the trial, Summit's antibody drug ivonescimab was administered along with platinum-based chemotherapy against the current standard of care, tislelizumab, which is made by BeiGene (NASDAQ: BGNE), in patients with locally advanced or metastatic squamous non-small cell lung cancer (NSCLC).
Tempus AI Is Skyrocketing Today -- Is the Stock a Buy Right Now?
Amid a bullish backdrop for the broader market, Tempus AI (NASDAQ: TEM) stock is posting big gains Wednesday. In addition to buying momentum that's lifting valuations across the broader market, Tempus AI stock is climbing thanks to news that the company has formed a new partnership with AstraZeneca and Pathos AI. Is Tempus AI stock a buy right now?
Novavax Signals Chances Of FDA Approval For Its COVID-19 Vaccine: But Retail Sentiment Wavers
The company announced on Wednesday that it had received formal communication from the FDA in the form of an information request for a “postmarketing commitment” to generate additional clinical data.
Amicus Therapeutics to Report Q1 Earnings: What's in the Cards?
On FOLD's first-quarter 2025 earnings call, investors are likely to focus on the sales of lead drug Galafold and the combo drug, Pombiliti + Opfolda.
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know
Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Novavax Jumps After FDA Asks for More Data on Its Covid Vaccine
Novavax Inc. shares rose after US regulators asked for more data on its Covid vaccine, signaling the shot may be on a path to full approval despite US Health and Human Services Secretary Robert F. Kennedy Jr. raising doubts about its efficacy.
Verastem Oncology to Report Q1 Earnings: What's in the Cards?
Devoid of any marketed drugs, investors are set to focus on VSTM's pipeline updates when it reports first-quarter 2025 earnings.
Novavax Shares Plunge After RFK Jr. Questions Its Covid Vaccine
Novavax Inc. shares plunged as much as 26% after US Health and Human Services Secretary Robert F. Kennedy Jr. raised doubts about the efficacy of its Covid vaccine.
Dave Ramsey Reveals One Trait Among Successful Financial Transformations: 'Few People Have The Courage To Seek Out Change'
Financial guru Dave Ramsey has helped many people with his bestselling books and "The Ramsey Show." However, you can also get valuable insights from Ramsey by looking at his X feed. He recently put out an X post saying, "Change is painful. Few people have the courage to seek out change." While seeking change is intimidating for many people, it may be the exact shift you need to transform your finances. Don't Miss: Hasbro, MGM, and Skechers trust this AI marketing firm — invest pre-IPO from $0.55
2 Beaten-Down Stocks That Still Aren't Worth Buying
President Trump's trade policies are sending many stocks that were performing well in the wrong direction and exacerbating things for others that were already struggling. Consider two examples: Tilray (NASDAQ: TLRY) and Novavax (NASDAQ: NVAX). Tilray's shares have dropped significantly this year and are worth about 58 cents apiece as of this writing.
Mentions: TLRY
Novavax, Inc. (NVAX): Among Unstoppable Stocks That Could Double Your Money
We recently published a list of 10 Unstoppable Stocks That Could Double Your Money. In this article, we are going to take a look at where Novavax, Inc. (NASDAQ:NVAX) stands against other unstoppable stocks that could double your money. Generating significant returns and multiplying their money in the stock market remains a primary goal for […]
Jaguar Land Rover to enact shipment pause to US in April as it develops post-tariff plans
The British maker of Jaguar and Land Rover cars is pausing shipments to the U.S. as it works to mitigate the impact of a 25% tax on vehicle imports imposed by the Trump Administration. Jaguar Land Rover Automotive, one of Britain’s biggest carmakers, said Saturday that the pause would take place this month. “The USA is an important market for JLR’s luxury brands,” the company said in a statement.
Biotech Stocks Fall After Top FDA Official Quits Over Clash With RFK Jr.
The decline in biotech stocks comes after FDA official Peter Marks' resignation, citing irreconcilable differences with the new HHS Secretary.
Why Biotech Stocks Like Recursion Pharmaceuticals, CRISPR Therapeutics, and Summit Therapeutics Plunged Today
All three companies are early-stage biotechnology companies working on next-generation therapeutics with advanced technologies. Over the weekend, Dr. Peter Marks, who headed the FDA's Center for Biologics Evaluation and Research, as well as its vaccine division, resigned in protest.
Moderna, Vaxcyte, Novavax Hammered After Key FDA Official Peter Marks Resigns
Peter Marks heads up the department in charge of reviewing vaccines, genetic medicines and cell therapies.
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It
Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store.